Paul Schneider

I’m a Postdoctoral Fellow at the Church Lab (Harvard/Wyss) developing next-gen gene therapies for Parkinson’s and Alzheimer’s. Instead of treating symptoms, I target fundamental drivers of cellular aging to reprogram our biology. How can we enhance the resilience of neurons to age-related degeneration and use genetic programs of youth to forestall neurodegenerative disease?